Poster (download)
[pdf-embedder url=”https://bgrssb.icgbio.ru/wp-content/uploads/2020/07/320.pdf”]
Larisa A. Oleynik1
1Research Institute of Clinical and Experimental Lymphology – a branch of the Institute of Cytology and Genetics of Siberian Branch of Russian Academy of Sciences, larisaoleynik81@gmail.com
The relevance of this project is due to the ability to create a domestic highly effective, safe and inexpensive drug based on pegylated interferon lambda (PEG-interferon-О»1). Therefore, it is very important to conduct a preclinical study of the mutagenic properties of the drug based on PEG-interferon-О»1 in experimental animals and in the somatic mosaic test system